As filed with the Securities and Exchange Commission on November 28, 2001
                                                 Registration No. 333- _________

================================================================================

                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                  -----------

                         Form S-3 Registration Statement

                        Under the Securities Act of 1933

                                  -----------

                                    CRAY INC.
             (Exact name of registrant as specified in its charter)

                                  -----------

        WASHINGTON                                     93-0962605
        (State or other jurisdiction                   (IRS Employer
        of incorporation or organization)              Identification No.)

                             411 First Avenue South
                                    Suite 600
                                Seattle, WA 98104
                           (206) 701-2000 (telephone)
                           (206) 701-2500 (facsimile)
       (Address, including zip code, and telephone and facsimile numbers,
              including area code, of principal executive offices)

                                   -----------

                   Kenneth W. Johnson, Chief Financial Officer
                                    Cray Inc.
                             411 First Avenue South
                                    Suite 600
                                Seattle, WA 98104
                           (206) 701-2000 (telephone)
                           (206) 701-2500 (facsimile)
              (Name, address, including zip code, and telephone and
          facsimile numbers, including area code, of agent for service)

                                    Copy to:
                             L. John Stevenson, Jr.
                                 Stoel Rives LLP
                          One Union Square, 36th Floor
                             Seattle, WA 98101-3197
                           (206) 624-0900 (telephone)
                           (206) 386-7500 (facsimile)

        APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:
      From time to time after this registration statement becomes effective



If the only securities being registered on this Form are to be offered pursuant
to dividend or interest reinvestment plans, please check the following box. [ ]

If any of the securities being registered on this Form are to be offered on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with a dividend or
interest reinvestment plan, check the following box. [X]

If this Form is filed to register additional securities for an offering pursuant
to Rule 462(b) under the Securities Act, please check the following box and list
the Securities Act registration statement number of the earlier effective
registration statement for the same offering. [ ]

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under
the Securities Act, check the following box and list the Securities Act
registration number of the earlier effective registration statement for the same
offering. [ ]

If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. [ ]

                        CALCULATION OF REGISTRATION FEE



====================== ==================== =================== ==================== ===================
Title of Each Class                         Proposed Maximum    Proposed Maximum
of Securities          Amount to be         Offering Price      Aggregate Offering   Amount of
Registered             Registered (1)       Per Share (2)       Price (2)            Registration Fee
---------------------- -------------------- ------------------- -------------------- -------------------
                                                                         
Common Stock, $.01     8,282,484 shares           $2.07           $17,144,741.00         $4,286.19
par value
====================== ==================== =================== ==================== ===================


(1) Represents shares of common stock issuable (i) upon conversion of the 5%
convertible subordinated debentures; (ii) as payment of interest on the 5%
convertible subordinated debentures; (iii) for other payments due under the
debentures and related transaction documents; and (iv) upon exercise of the
stock purchase warrants described herein. Pursuant to Rule 416 under the
Securities Act, this registration statement also covers a presently
indeterminate number of common shares issuable under the debentures, warrants
and related transaction documents upon the occurrence of stock dividends, stock
splits or similar transactions.

(2) The proposed maximum offering price per share and maximum aggregate offering
price for the shares being registered hereby are calculated in accordance with
Rule 457(c) under the Securities Act using the average of the high and low
prices on November 26, 2001.

The registrant hereby amends this registration statement on such date or dates
as may be necessary to delay its effective date until the registrant shall file
a further amendment which specifically states that this registration statement
shall thereafter become effective in accordance with section 8(a) of the
Securities Act of 1933 or until the registration statement shall become
effective on such date as the Securities and Exchange Commission, acting
pursuant to said section 8(a), may determine.





PROSPECTUS, Subject to Completion, dated November 28, 2001

                                    CRAY INC.

                        8,282,484 shares of common stock

        These shares of common stock are issuable upon conversion of, or as
payment of interest on, the 5% convertible subordinated debentures, shares
issuable for other payments due under the debentures and related transaction
documents, and shares issuable upon exercise of the stock purchase warrants
owned by the selling shareholders listed on page 3.

        The selling shareholders may sell the shares from time to time at fixed
prices, market prices, prices computed with formulas based on market prices, or
at negotiated prices, and may engage a broker or dealer to sell the shares. We
will not receive any proceeds from the sale of the shares, but we will bear the
costs relating to the registration of the shares.

        Our common stock is traded on the Nasdaq National Market under the
symbol "CRAY." On November 27, 2001, the closing price for our common stock was
$2.05 per share.

                         -------------------------------

        THE SHARES OFFERED IN THIS PROSPECTUS INVOLVE A HIGH DEGREE OF RISK. YOU
SHOULD CAREFULLY CONSIDER THE "FACTORS THAT COULD AFFECT FUTURE RESULTS"
CONTAINED IN OUR QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTER ENDING SEPTEMBER
30, 2001, THE "ADDITIONAL FACTORS THAT COULD AFFECT FUTURE RESULTS" IN OUR
CURRENT REPORT ON FORM 8-K FILED ON NOVEMBER 28, 2001, AND SIMILAR DISCLOSURES
IN OUR FUTURE FILINGS MADE WITH THE SECURITIES AND EXCHANGE COMMISSION, WHICH
ARE INCORPORATED BY REFERENCE IN THIS PROSPECTUS, IN DETERMINING WHETHER TO
PURCHASE SHARES OF OUR COMMON STOCK.

                         -------------------------------

        NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES
COMMISSION HAS APPROVED OR DISAPPROVED THE SHARES, OR DETERMINED IF THIS
PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.

                         -------------------------------

               The date of this prospectus is ____________, 2001.






                                TABLE OF CONTENTS



Section                                                               Page
-------                                                               ----
                                                                   
Our Business.....................................................       3
Selling Shareholders ............................................       3
Plan of Distribution ............................................       4
Legal Matters ...................................................       5
Experts .........................................................       5
Limitation of Liability and Indemnification .....................       6
Information Incorporated by Reference ...........................       6
Available Information ...........................................       7




        You should rely only on information contained or incorporated by
reference in this prospectus. See "Information Incorporated by Reference" on
page 6. Neither Cray nor the selling shareholders have authorized any other
person to provide you with information different from that contained in this
prospectus.

        The shares of common stock are not being offered in any jurisdiction
where the offering is not permitted.


                                      -2-


                                  OUR BUSINESS

        We design, build, sell and service high-performance computer systems,
sometimes referred to as "supercomputers." Our executive offices are located at
Merrill Place, Suite 600, 411 First Avenue South, Seattle, WA 98104-2860, and
our telephone number is (206) 701-2000.

                              SELLING SHAREHOLDERS

        On November 6 and 15, 2001, in a private placement under the Securities
Act, we sold to six accredited investors (i) 5% convertible subordinated
debentures in the aggregate original principal amount of $9,300,000, convertible
into shares of our common stock and (ii) stock purchase warrants for an
aggregate of 367,590 shares of our common stock at an initial exercise price of
$4.4275 per share, subject to adjustment, exercisable until November 6, 2004.
The purchasers were the six selling shareholders listed in the table below. We
received gross proceeds of $9,300,000 in exchange for the issuance of the
debentures and the warrants, and after payment of expenses we expect net
proceeds of approximately $8,550,000.



                                                                     Ownership After Offering
                                                                      if All Shares Offered
                              Shares Owned                               Hereby Are Sold
                                Prior to          Shares Being       ------------------------
   Selling Shareholders        Offering(1)         Offered(2)        Shares         Percent
   --------------------       ------------        ------------       ------         -------
                                                                        
Riverview Group, LLC            4,452,947          4,452,947           0               0

Omicron Partners, LP            1,781,180          1,781,180           0               0

Laterman & Co.                    445,295           445,295            0               0

Forevergreen Partners             445,295           445,295            0               0

Clarion Capital
Corporation                       890,590           890,590            0               0

The Morton A. Cohen
Revocable Living Trust            267,177           267,177            0               0



        (1) Assumes a total of (i) 7,914,894 shares issuable upon conversion of
the convertible debentures (calculated as 200% of the shares issuable using the
fixed conversion price of $2.35 per share); and (ii) 367,590 shares of common
stock issuable upon exercise of the warrants.

        (2) Represents the number of shares issuable upon conversion of the
convertible subordinated debentures, in any payment of interest made on the
debentures in shares of common stock, for any other payments due under the
debentures and related transaction documents, and upon exercise of the warrants
calculated as described in note (1) above. The


                                      -3-


actual number of shares of common stock issued upon the conversion of the
convertible subordinated debentures and the payment of interest thereon depends
on factors which we cannot predict at this time, including the times at which
the selling shareholders may elect to convert the debentures and the market
prices of our common stock at such times.

        None of the selling shareholders has had any material relationship with
us or any of our affiliates within the past three years.

        In recognition of the fact that each selling shareholder may wish to be
legally permitted to sell its shares when it deems appropriate, we have agreed
with the selling shareholders to file with the SEC, under the Securities Act of
1933, a registration statement on Form S-3, of which this prospectus forms a
part, with respect to the resale of the shares, and we have agreed to prepare
and file such amendments and supplements to the registration statement as may be
necessary to keep the registration statement effective until the shares are no
longer required to be registered for sale by the selling shareholders.

                              PLAN OF DISTRIBUTION

        We are registering the shares covered by this prospectus for the selling
shareholders. The selling shareholders and their pledgees, donees, transferees
or other successors in interest may sell the shares in the over-the-counter
market or otherwise, at market prices prevailing at the time of sale, at prices
related to prevailing market prices, or at negotiated prices. In addition, the
shares may be sold by one or more of the following methods:

        - a block trade in which a broker or dealer so engaged will attempt to
          sell the shares as agent but may position and resell a portion of the
          block, as principal, in order to facilitate the transaction;

        - purchases by a broker or dealer, as principal, in a market maker
          capacity or otherwise and resale by the broker or dealer for its
          account pursuant to their prospectus;

        - ordinary brokerage transactions and transactions in which a broker
          solicits purchases;

        - privately negotiated transactions;

        - any combination of these methods of sale; or

        - any other legal method.

        We will pay the costs and fees of registering the shares, but the
selling shareholders will pay any brokerage commissions, discounts or other
expenses relating to the sale of the shares. We have agreed with the selling
shareholders to indemnify each other against certain liabilities, including
liabilities arising under the Securities Act, that relate to statements or
omissions in the registration statement of which this prospectus forms a part.


                                      -4-


        Regulation M under the Securities Exchange Act of 1934 provides that
during the period that any person is engaged in the distribution, as so defined
in Regulation M, of our common stock, such person generally may not purchase
shares of our common stock. The selling shareholders are subject to applicable
provisions of the Securities Act and the Securities Exchange Act of 1934 and the
rules and regulations thereunder, including, without limitation, Regulation M,
which provisions may limit the timing of purchases and sales of shares of our
common stock by the selling shareholders. The foregoing may affect the
marketability of our common stock.

        The selling shareholders may negotiate and pay brokers or dealers
commissions, discounts or concessions for their services. In effecting sales,
brokers or dealers engaged by the selling shareholders may allow other brokers
or dealers to participate. However, the selling shareholders and any brokers or
dealers involved in the sale or resale of the shares may qualify as
"underwriters" within the meaning of the Section 2(a)(11) of the Securities Act.
In addition, the brokers' or dealers' commissions, discounts or concessions may
qualify as underwriters' compensation under the Securities Act. If any of the
selling shareholders qualifies as an "underwriter," it will be subject to the
prospectus delivery requirements of section 5(b)(2) of the Securities Act.

        In addition to selling its shares under this prospectus, the selling
shareholders may:

        - agree to indemnify any broker or dealer or agent against certain
          liabilities related to the selling of the shares, including
          liabilities arising under the Securities Act;

        - transfer its shares in other ways not involving market makers or
          established trading markets, including directly by gift, distribution,
          or other transfer; or

        - sell their shares under Rule 144 of the Securities Act rather than
          under this prospectus, if the transaction meets the requirements of
          Rule 144.

        Upon notification by the selling shareholders that any material
arrangement has been entered into with a broker or dealer for the sale of the
shares through a block trade, special offering, exchange distribution or
secondary distribution or a purchase by a broker or dealer, we will file a
supplement to this prospectus, if required, pursuant to Rule 424(b) under the
Securities Act, disclosing the material terms of the transaction.

                                  LEGAL MATTERS

        For purposes of this offering, Kenneth W. Johnson, our General Counsel,
is giving an opinion on the validity of the common shares. As of the date of
this prospectus, Mr. Johnson held 40,914 shares of our common stock, options to
purchase 270,000 shares of our common stock and warrants to purchase 21,637
shares of our common stock.

                                     EXPERTS

        The financial statements incorporated in this prospectus by reference
from our Annual Report on Form 10-K/A for the year ended December 31, 2000, have
been audited by Deloitte


                                      -5-


& Touche LLP, independent auditors, as stated in their report, which is
incorporated herein by reference. The statements of assets acquired and
liabilities assumed of the Cray Research business unit of Silicon Graphics, Inc.
as of March 31, 2000, and the related statements of revenue and direct operating
expenses for the years ended June 30, 1998 and 1999, and the nine month period
ended March 31, 2000, incorporated in this prospectus by reference from Form
8-K/A of Cray Inc. filed on June 16, 2000, have been audited by Deloitte &
Touche LLP, independent auditors, as stated in their report (which report
expresses an unqualified opinion and includes an explanatory paragraph referring
to note 1 which describes the expense allocations by Silicon Graphics, Inc),
which is incorporated herein by reference. These financial statements have been
so incorporated herein by reference in reliance upon the reports of such firm
given upon their authority as experts in accounting and auditing.

                   LIMITATION OF LIABILITY AND INDEMNIFICATION

        Our Restated Articles of Incorporation provide that, to the fullest
extent permitted by the Washington Business Corporation Act, our directors will
not be liable for monetary damages to us or our shareholders, excluding,
however, liability for acts or omissions involving intentional misconduct or
knowing violations of law, illegal distributions or transactions from which the
director receives benefits to which the director is not legally entitled. Our
Restated Bylaws provide that we will indemnify our directors and, by action of
the Board of Directors, may indemnify our officers, employees and other agents
to the fullest extent permitted by applicable law, except for any legal
proceeding that is initiated by such directors, officers, employees or agents
without authorization of the Board of Directors.

        Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to our directors, officers and controlling persons pursuant
to the foregoing provisions, or otherwise, we have been advised that, in the
opinion of the SEC, such indemnification is against public policy as expressed
in the Securities Act and is, therefore, unenforceable.

                     INFORMATION INCORPORATED BY REFERENCE

        The Securities and Exchange Commission allows us to incorporate by
reference our publicly-filed reports into this prospectus, which means that
information included in those reports is considered part of this prospectus.
Information that we file with the Securities and Exchange Commission after the
date of this prospectus will automatically update and supersede the information
contained in this prospectus. We incorporate by reference the following
documents filed with the Securities and Exchange Commission and any future
filings made with the Securities and Exchange Commission under sections 13(a),
13(c), 14 or 15(d) of the Securities Exchange Act of 1934:

        1.  Our annual report on Form 10-K/A for the year ended December 31,
            2000, as filed on September 17, 2001;

        2.  Our quarterly reports on Form 10-Q for the quarters ended March 31,
            2001, June 30, 2001, and September 30, 2001;

        3.  Our definitive proxy statement, as filed with the Securities and
            Exchange Commission on April 9, 2001;


                                      -6-


        4.  Our current report on Form 8-K for the event of November 6, 2001, as
            filed on November 28, 2001;

        5.  Our current report on Form 8-K for the event of October 1, 2001 as
            filed on October 10, 2001;

        6.  Our current report on Form 8-K for the event of May 10, 2001, as
            filed on May 14, 2001;

        7.  Our current report on Form 8-K for the event of April 3, 2001, as
            filed on April 13, 2001;

        8.  Our current report on Form 8-K for the event of February 7, 2001, as
            filed on February 15, 2001;

        9.  Our current report on Form 8-K/A for the event of December 15, 2000,
            as filed on July 27, 2001;

        10. Our current report on Form 8-K for the event of April 3, 2000, as
            filed on April 5, 2000 and amended on June 16, 2000; and

        11. The description of our common stock as described in our registration
            statement on Form SB-2, registration no. 33-95460-LA, including any
            amendment or report filed for the purpose of updating the
            description, as incorporated by reference in our registration
            statement on Form 8-A, registration no. 0-26820, including the
            amendment on Form 8-A/A.

        We will furnish without charge to you, on written or oral request, a
copy, excluding exhibits, of any or all of the documents incorporated by
reference. You should direct any requests for documents to Investor Relations,
Cray Inc., 411 First Avenue South, Suite 600, Seattle, Washington 98104,
telephone (206) 701-2000.

        The information relating to us contained in this prospectus is not
comprehensive and should be read with the information contained in the
incorporated documents.

                              AVAILABLE INFORMATION

        This prospectus is part of a registration statement on Form S-3 that we
filed with the SEC. Certain information in the registration statement has been
omitted from this prospectus in accordance with SEC rules.

        We file annual, quarterly and special reports and other information with
the SEC. You may read and copy the registration statement and any other document
that we file at the SEC's public reference rooms located at Room 1024, Judiciary
Plaza, 450 Fifth Street N.W., Washington, D.C. 20549; 233 Broadway, New York,
New York 10048; and Citicorp Center, 500 West Madison Street, Suite 1400,
Chicago, Illinois 60661. Please call the SEC at 1-800-SEC-0330 for further
information on the public reference rooms. Our SEC filings are also available to
you free of charge at the SEC's web site at http://www.sec.gov.


                                      -7-


        Statements contained in this prospectus as to the contents of any
contract or other document referred to are not necessarily complete. You should
refer to the copy of such contract or other document filed as an exhibit to the
registration statement.


                                      -8-


                                     PART II

                   INFORMATION NOT REQUIRED IN THE PROSPECTUS

Item 14. Other Expenses of Issuance and Distribution.

        We will pay all expenses in connection with the issuance and
distribution of the securities being registered. The following is an itemized
statement of these expenses (all amounts are estimated except for the SEC fees):


                                                                     
        SEC Registration fee.....................................       $  4,286
        Legal fees...............................................       $ 75,000
        Accountant's Fees........................................       $  8,000
        Finder's Fee.............................................       $651,000
        Miscellaneous............................................       $ 11,714
                                                                        --------
        Total....................................................       $750,000
                                                                        ========



Item 15. Indemnification of Officers and Directors.

        Article XII of our Restated Articles of Incorporation and Section 11 of
our Restated Bylaws require indemnification of our directors, officers,
employees and agents to the fullest extent permitted by the Washington Business
Corporation Act (the "Act"). Sections 23B.08.500 through 23B.08.600 of the Act
authorize a court to award, or a corporation's board of directors to grant,
indemnification to directors and officers on terms sufficiently broad to permit
indemnification under certain circumstances for liabilities arising under the
Securities Act.

        Section 23B.08.320 of the Act authorizes a corporation to limit a
director's liability to the corporation or its shareholders for monetary damages
for acts or omissions as a director, except in certain circumstances involving
intentional misconduct, self-dealing or illegal corporate loans or
distributions, or any transaction from which the director personally receives a
benefit in money, property or services to which the director is not legally
entitled. Article XI of our Restated Articles of Incorporation contains
provisions implementing, to the fullest extent permitted by Washington law, such
limitations on a director's liability to us and our shareholders.

Item 16. Exhibits.

        4.1 Convertible Subordinated Debentures and Warrants Purchase Agreement
            dated as of November 6, 2001 between Cray Inc. and the selling
            shareholders(1)


                                      II-1


        4.2 Form of 5% Convertible Subordinated Debenture, due November 6, 2004,
            issued to the selling shareholders(1)

        4.3 Form of Stock Purchase Warrant, dated November 6, 2001, issued to
            the selling shareholders(1)

        4.4 Registration Rights Agreement dated as of November 6, 2001 between
            Cray Inc. and the selling shareholders(1)

        4.5 Amendment No. 1 to the Convertible Subordinated Debentures and
            Warrants Purchase Agreement and Other Transaction Documents, dated
            as of November 15, 2001, between Cray Inc. and the selling
            shareholders(1)

        5   Opinion on Legality

        23  Consent of Deloitte & Touche LLP

        24  Power of Attorney (included on signature page hereof)

---------------
(1) Incorporated by reference to our current report on Form 8-K as filed on
November 28, 2001


Item 17. Undertakings.

        (a) The undersigned registrant hereby undertakes:

                (1) To file, during any period in which offers or sales are
                    being made, a post-effective amendment to this Registration
                    Statement

                    (i)     To include any prospectus required by Section
                            10(a)(3) of the Securities Act of 1933;

                    (ii)    To reflect in the prospectus any facts or events
                            arising after the effective date of this
                            Registration Statement (or the most recent
                            post-effective amendment thereof) that, individually
                            or in the aggregate, represent a fundamental change
                            in the information set forth in this Registration
                            Statement; and

                    (iii)   To include any material information with respect
                            to the plan of distribution not previously disclosed
                            in the registration statement or any material change
                            to such information in the registration statement;

                      provided, however, that paragraphs (a)(1)(i) and
                      (a)(1)(ii) do not apply if the information required to be
                      included in a post-effective amendment by those paragraphs
                      is contained in periodic reports filed with or furnished
                      to the Commission by the registrant pursuant to Section 13
                      or Section 15(d) of the Exchange Act that are incorporated
                      by reference in the registration statement;


                                      II-2


               (2)    That, for the purpose of determining any liability under
                      the Securities Act, each post-effective amendment shall be
                      deemed to be a new registration statement relating to the
                      securities offered therein, and the offering of such
                      securities at that time shall be deemed to be the initial
                      bona fide offering thereof; and

               (3)    To remove from registration by means of a post-effective
                      amendment any of the securities being registered that
                      remain unsold at the termination of the offering.

        (b) The undersigned registrant hereby undertakes that, for purposes of
            determining any liability under the Securities Act of 1933, each
            filing of the registrant's annual report pursuant to Section 13(a)
            or Section 15(d) of the Securities Exchange Act of 1934 that is
            incorporated by reference in the registration statement shall be
            deemed to be a new registration statement relating to the securities
            offered therein, and the offering of such securities at that time
            shall be deemed to be the initial bona fide offering thereof.

        (c) Insofar as indemnification for liabilities arising under the
            Securities Act may be permitted to directors, officers and
            controlling persons of the registrant pursuant to the foregoing
            provisions, or otherwise, the registrant has been advised that in
            the opinion of the Commission such indemnification is against public
            policy as expressed in the Securities Act and is, therefore,
            unenforceable. In the event that a claim for indemnification against
            such liabilities (other than the payment by the registrant of
            expenses incurred or paid by a director, officer or controlling
            person of the registrant in the successful defense of any action,
            suit or proceeding) is asserted by such director, officer or
            controlling person in connection with the securities being
            registered, the registrant will, unless in the opinion of its
            counsel the matter has been settled by controlling precedent, submit
            to a court of appropriate jurisdiction the question, whether such
            indemnification by it is against public policy as expressed in the
            Securities Act and will be governed by the final adjudication of
            such issue.


                                      II-3



                                   SIGNATURES

        Pursuant to the requirements of the Securities Act of 1933, as amended,
the registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-3 and has duly caused this
Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Seattle, State of Washington, on November 28,
2001.

                                            CRAY INC.

                                            By: /S/
                                               ---------------------------------
                                               Michael P. Haydock
                                               President and Chief Executive
                                               Officer





        Each of the undersigned hereby constitutes and appoints James E.
Rottsolk, Michael P. Haydock and Kenneth W. Johnson, and each of them, the
undersigned's true and lawful attorney-in-fact and agent, with full power of
substitution, for the undersigned and in his or her name, place and stead, in
any and all capacities, to sign any or all amendments or post-effective
amendments to this Registration Statement, and any other instruments or
documents that said attorneys-in-fact and agents may deem necessary or
advisable, to enable Cray Inc. to comply with the Securities Act of 1933, as
amended, and any requirements of the Securities and Exchange Commission in
respect thereof, and to file the same, with all exhibits thereto, with the
Securities and Exchange Commission, granting unto said attorneys-in-fact and
agents and each of them full power and authority to do and perform each and
every act and thing requisite and necessary to be done, as fully to all intents
and purposes as the undersigned might or could do in person, hereby ratifying
and confirming all that each such attorney-in-fact and agent, or his substitute,
may lawfully do or cause to be done by virtue hereof.

        Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed by the following persons in the
capacities indicated below on the 28th day of November, 2001:

Signature and Title

 /S/                                         /S/
-----------------------------------         ------------------------------------
James E. Rottsolk, Chairman of the          Daniel J. Evans, Director
Board of Directors

 /S/                                         /S/
-----------------------------------         ------------------------------------
Burton J. Smith, Director                   Stephen C. Kiely, Director

 /S/                                         /S/
-----------------------------------         ------------------------------------
Terren S. Peizer, Director                  Kenneth W. Kennedy, Director

 /S/                                         /S/
-----------------------------------         ------------------------------------
David N. Cutler, Director                   William A. Owens, Director

 /S/                                         /S/
-----------------------------------         ------------------------------------
Dean D. Thornton, Director                  Kenneth W. Johnson
                                            Chief Financial Officer

 /S/                                         /S/
-----------------------------------         ------------------------------------
Douglas C. Ralphs, Chief Accounting         Michael P. Haydock, President,
Officer                                     Chief Executive Officer and Director